Awards & Advancement

Recursion wins award for drug discovery platform

Monday, December 26, 2016

Recursion Pharmaceuticals announced that it has won two Fierce Innovation awards from the biotech and pharmaceutical industries today for its innovative platform. The awards, “Best Biotech Innovation” and “Best In Show—New Product or Service,” recognize Recursion’s disruptive combination of experimental biology and artificial intelligence applied to drug discovery.

[Read More]

Bracket add Lewis Fredane as clinical vice president

Wednesday, December 21, 2016

Bracket, a clinical trial technology and specialty services provider, announced the addition of Clinical Vice President Lewis M. Fredane, M.D., to its global team. A board certified neurologist with more than 30 years of clinical research experience, Fredane brings a strategic combination of clinical and industry research expertise to his new role.

[Read More]

HHS appoints Quorum’s Dr. Stephen Rosenfeld SACHRP Chair

Wednesday, December 21, 2016

Dr. Stephen J. Rosenfeld, executive IRB chair for Quorum Review IRB, has accepted an invitation from Sylvia Burwell, the Secretary of the Department of Health and Human Services (DHHS), to chair the Secretary’s Advisory Committee for Human Research Protections (SACHRP). SACHRP comprises experts in the fields of research and ethics, and provides advice and recommendations to the Secretary of DHHS on issues pertaining to the protection of human subjects in research.

[Read More]

Theranos adds John McChesney and Tali Mackay

Tuesday, December 13, 2016

Theranos has announced that key roles have been filled in the company’s executive ranks, with the naming of John McChesney to senior vice president of operations and Tali Mackay to senior vice president of corporate communications and investor relations, as well as the promotion of David Taylor to the role of general counsel. Dr. Gregory J. Tsongalis was appointed to the company’s Scientific and Medical Advisory Board (SMAB).

[Read More]

Major General James Gilman, M.D., to lead NIH Clinical Center

Monday, December 12, 2016

NIH Director Francis S. Collins, M.D., Ph.D., has announced the selection of Major General James K. Gilman, M.D., U.S. Army (Retired), as the inaugural chief executive officer of the NIH Clinical Center, the nation’s largest hospital devoted to clinical research. Dr. Gilman is expected to join in early January 2017.

[Read More]

Spotlight Innovation appoints Chitra Edwin SVP of Regulatory Affairs and Compliance

Thursday, December 8, 2016

Spotlight Innovation, a pharmaceutical company advancing technologies designed to address rare, emerging and neglected diseases, has announced the appointment of Chitra Edwin, Ph.D., RAC, as senior vice president of Regulatory Affairs and Compliance. Dr. Edwin will provide leadership for all U.S. and international regulatory matters including strategic planning for regulatory approvals, preparation of regulatory submissions, serving as the primary contact with the FDA and other regulatory authorities, and ensuring compliance with regulatory requirements.

[Read More]